You cannot add another "Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma" to your cart. View cart

Article: Pathological diagnosis and molecular testing in non-small cell lung cancer: Belgian guidelines

€2.42

SKU: product-article-11082 Category: General

Description
Reviews (0)

Description

Pathological diagnosis and molecular testing in non-small cell lung cancer: Belgian guidelines

Reviews

There are no reviews yet.

Be the first to review “Article: Pathological diagnosis and molecular testing in non-small cell lung cancer: Belgian guidelines”

Top

Article: Pathological diagnosis and molecular testing in non-small cell lung cancer: Belgian guidelines

Description

Reviews

Related products

Article: Highlights in respiratory oncology

Article: Highlights in gynaecological cancers

Article: Highlights in breast cancer

Article: Highlights in melanoma